Celik Atac, Aytan Pelin, Dursun Huseyin, Koc Fatih, Ozbek Kerem, Sagcan Mustafa, Kadi Hasan, Ceyhan Koksal, Onalan Orhan, Onrat Ersel
Cardiology Department, Faculty of Medicine, Gaziosmanpasa University, Tokat, Turkey.
Ann Noninvasive Electrocardiol. 2011 Oct;16(4):344-50. doi: 10.1111/j.1542-474X.2011.00461.x.
Cardiac autonomic dysfunction may develop in patients with clinical or subclinical thyroid hormone deficiency. Heart rate variability (HRV) and heart rate turbulence (HRT) are used for evaluating changes in cardiac autonomic functions and also used to provide risk stratification in cardiac and noncardiac diseases. The aim of this study is to evaluate cardiac autonomic functions before and 6 months after thyroid replacement therapy in patients with thyroid hormone deficiency.
Forty hypothyroid patients (mean age 48 ± 13, four male) and 31 healthy controls (mean age 51 ± 12, three male) were included in the study. Twenty-four hour ambulatory electrocardiogram recordings were taken using Pathfinder Software Version V8.255 (Reynolds Medical). The time domain parameters of HRV analysis were performed using the Heart Rate Variability Software (version 4.2.0, Norav Medical Ltd, Israel). HRT parameters, Turbulence Onset (TO), and Turbulence Slope (TS) were calculated with HRT! View Version 0.60-0.1 software.
HRV and HRT parameters were decreased in the patient group (SDNN; P < 0.001, SDANN; P < 0.009, RMSSD; P = 0.049, TO; P = 0.035, TS; P < 0.001). After 6 months of thyroid replacement therapy, there were no significant changes observed in either HRV or HRT.
Hypothyroidism may cause cardiac autonomic dysfunction. Treating hypothyroidism with L-thyroxine therapy does not effectively restore cardiac autonomic function. HRV and HRT can be used as to help monitor cardiovascular-related risk in this population.
临床或亚临床甲状腺激素缺乏的患者可能会出现心脏自主神经功能障碍。心率变异性(HRV)和心率震荡(HRT)用于评估心脏自主神经功能的变化,也用于对心脏疾病和非心脏疾病进行危险分层。本研究的目的是评估甲状腺激素缺乏患者在甲状腺替代治疗前及治疗6个月后的心脏自主神经功能。
本研究纳入了40例甲状腺功能减退患者(平均年龄48±13岁,男性4例)和31例健康对照者(平均年龄51±12岁,男性3例)。使用Pathfinder软件版本V8.255(Reynolds Medical)进行24小时动态心电图记录。HRV分析的时域参数使用心率变异性软件(版本4.2.0,以色列Norav Medical Ltd公司)进行测量。HRT参数,即震荡起始(TO)和震荡斜率(TS),使用HRT! View版本0.60 - 0.1软件进行计算。
患者组的HRV和HRT参数降低(SDNN;P < 0.001,SDANN;P < 0.009,RMSSD;P = 0.049,TO;P = 0.035,TS;P < 0.001)。甲状腺替代治疗6个月后,HRV或HRT均未观察到显著变化。
甲状腺功能减退可能导致心脏自主神经功能障碍。用左旋甲状腺素治疗甲状腺功能减退并不能有效恢复心脏自主神经功能。HRV和HRT可用于帮助监测该人群心血管相关风险。